Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Leases (2020 - 2025)

Cryo Cell International (CCEL) has disclosed Current Leases for 6 consecutive years, with $430221.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases changed 0.44% to $430221.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $430221.0, a 0.44% change, with the full-year FY2025 number at $430221.0, changed 0.44% from a year prior.
  • Current Leases was $430221.0 for Q4 2025 at Cryo Cell International, down from $465231.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $465231.0 in Q2 2025 to a low of $224729.0 in Q2 2023.
  • A 5-year average of $339722.2 and a median of $313963.5 in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: dropped 24.19% in 2023, then skyrocketed 89.79% in 2024.
  • Cryo Cell International's Current Leases stood at $312067.0 in 2021, then fell by 4.61% to $297691.0 in 2022, then decreased by 24.19% to $225686.0 in 2023, then surged by 89.79% to $428334.0 in 2024, then grew by 0.44% to $430221.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Current Leases are $430221.0 (Q4 2025), $465231.0 (Q2 2025), and $452014.0 (Q1 2025).